59-05-032 Proceeding

204 Proceedings of the Princess Maha Chakri Sirindhorn Congress involvement, 60 cases (37%) had heart involvement, 91 (55.8%) had lung involvement, 20 (12.3%) had diabetes mellitus, and 70 (40.9%) had hypertension. The prevalence of CNS involvement at the time of data analysis was 24% (163/691). Table 1 shows demographic data for all patients. Table 1 Demographic data for 691 patients with systemic lupus erythematosus (SLE) Male (%) 11.3 (78/691) Age at onset (years) 36.3 ± 16.4 SLE duration (years) 8.6 ± 7.1 Clinical features Malar rash (%) 45.1 (304/674) Discoid rash (%) 9.3 (63/675) Photosensitivity (%) 13.3 (90/675) Oral ulcer (%) 25.3 (171/675) Arthritis (%) 53.1 (359/676) Serositis (%) 36.2 (250/691) Proteinuria (%) 60.0 (412/687) Cellular cast (%) 15.0 (103/686) Anemia (%) 30.0 (206/689) Leukopenia (%) 52.8 (364/690) Lymphopenia (%) 74.3 (513/690) Thrombocytopenia (%) 44.3 (306/690) Psychosis (%) 7.4 (51/690) Seizure (%) 10.4 (72/690) C3 level 68.5 ± 32.8 C4 level 13.6 ± 9.6 Anti-dsDNA positivity 70.8 (488/689) Anti-Sm 37.9 (212/560) Anti-SSA 64.0 (315/492) Anti-SSB 30.3 (149/491) Anti-RNP 44.1 (246/558) Antiphospholipid Abs 36.0 (214/594) Comorbidity Hypertension 32.0 (221/690) Diabetes 7.4 (51/691) End Stage Renal Disease 9.0 (62/691) Cerebrovascular Disease 8.0 (55/691) Mortality 14.3 (99/691)